Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

347
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
347
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

458
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
458
Physiology of Enteric Nervous System and Gut Health01:05

Physiology of Enteric Nervous System and Gut Health

278
The gastrointestinal tract, responsible for the digestion and absorption of nutrients, is safeguarded by the intestinal barrier, which consists of secretory, physical, and immune components. At the forefront is the secretory barrier, composed of essential elements such as mucus, gut microbiota, and defense proteins. They collaborate to break down food particles, facilitate nutrient absorption, and maintain optimal gut health. These secretory components ensure the smooth functioning of the...
278
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

323
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
323
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

281
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
281
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

93
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
93

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cross-national analysis about the difference of histopathological management in Tis and T1 colorectal cancer between Japan and Korea.

Journal of the anus, rectum and colon·2019
Same author

Can image-enhanced endoscopy improve the diagnosis of Kyoto classification of gastritis in the clinical setting?

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2019
Same author

Situations Leading to Reduced Effectiveness of Current Hand Hygiene against Infectious Mucus from Influenza Virus-Infected Patients.

mSphere·2019
Same author

Effect of Repeated Consumption of Partially Hydrolyzed Guar Gum on Fecal Characteristics and Gut Microbiota: A Randomized, Double-Blind, Placebo-Controlled, and Parallel-Group Clinical Trial.

Nutrients·2019
Same author

Local recurrence and its risk factors after cold snare polypectomy of colorectal polyps.

Surgical endoscopy·2019
Same author

Helicobacter pylori eradication increases the serum high density lipoprotein cholesterol level in the infected patients with chronic gastritis: A single-center observational study.

PloS one·2019

相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

569

肠道脆弱性:它的概念和发病因子

Yuji Naito1

  • 1Human Immunology and Nutrition Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Digestion
|November 15, 2023
PubMed
概括

便秘是肠道脆弱的一个关键症状,与生存率降低和疾病风险增加有关. 解决肠道健康问题可能会通过准肠道微生物群失调症等机制来改善健康的预期寿命.

科学领域:

  • 老年学是一门学科.
  • 胃肠病学 胃肠病学
  • 微生物组研究 微生物组研究

背景情况:

  • 在日本,平均寿命和健康寿命之间存在很大的差异.
  • 肠道脆弱性越来越被认为是导致慢性炎症,疾病进展和整体脆弱性的因素.

研究的目的:

  • 突出肠道脆弱及其相关症状的意义.
  • 探索肠道脆弱的分子机制和潜在干预措施.

主要方法:

  • 审查最近关于肠道脆弱及其健康影响的研究.
  • 分析自我报告的症状,特别是便秘,作为肠道脆弱的指标.
  • 检查分子病理和肠道微生物群的作用.

主要成果:

  • 便秘是肠道脆弱的一个关键指标,与较低的存活率有关.
  • 肠道脆弱增加了慢性病,心血管疾病和神经退行性疾病的风险.
  • 早期的病理包括粘液分泌量下降和肠道微生物群失调.

结论:

  • 肠道脆弱,虽然没有得到广泛认可,但显著影响健康结果和寿命.
  • 针对肠道微生物群的干预措施,如益生菌,益生菌和便微生物群移植,显示出治疗潜力.
关键词:
衰老的衰老 衰老的衰老肠道的脆弱性 肠道的脆弱性伊祖莫尺度是一个尺度.长寿 长寿是一个问题.幸福是一种幸福.

更多相关视频

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.6K
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

8.4K

相关实验视频

Last Updated: Jul 11, 2025

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
04:00

Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles

Published on: July 26, 2024

569
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.6K
Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran
05:14

Assessment of Gut Barrier Integrity in Mice Using Fluorescein-Isothiocyanate-Labeled Dextran

Published on: November 18, 2022

8.4K
  • 未来的研究旨在开发用于肠道脆弱的实际查,诊断和干预策略.